Status:
COMPLETED
Canrenone Effects on Cardiovascular Mortality in Patients With Congestive Heart Failure (the Coffee-it Study)
Lead Sponsor:
University of Pavia
Conditions:
Cardiac Heart Failure Patients
Eligibility:
All Genders
18-90 years
Brief Summary
To evaluate canrenone effects compared to other therapies on cardiovascular mortality in patients with congestive heart failure and preserved systolic function after 12 years of evaluation.
Detailed Description
The investigators will verify patients with cardiac heart failure (CHF) and preserved systolic function and each patient must have all clinical evaluation through basal measurements of blood pressure,...
Eligibility Criteria
Inclusion
- patients with CHF
- preserved systolic function (FE ≥ 45%)
Exclusion
- severe hypertension identified by blood pressure ≥180/110 mmHg
- patients with impaired systolic function (FE \< 45%)
- history of active hepatitis or cirrhosis
- impaired renal function
- hyperpotassemia
- diabetes
Key Trial Info
Start Date :
July 13 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2017
Estimated Enrollment :
502 Patients enrolled
Trial Details
Trial ID
NCT03263962
Start Date
July 13 2017
End Date
November 30 2017
Last Update
February 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico San Matteo
Pavia, Italy, 27100